Neurodegenerative conditions from Alzheimer’s and Parkinson’s diseases to amyotrophic lateral sclerosis (ALS)—currently affect at least 6 million people in the United States alone.
There is not yet a solid treatment to slow or block these disorders from developing or progressing, but a review from June 2019 probed the impact of flavonoids, plant compounds that boast multiple biological activities on age-related changes in the brain contributing to neurodegeneration.